You just read:

Pervasis Receives Orphan Drug Designation in Europe for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis

News provided by

Pervasis Therapeutics, Inc.

Mar 01, 2011, 07:00 EST